In this Exclusive Interview transcript, George Bray talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston about viewing obesity as a chronic disease process and the future of treatment.
Read More »George Bray 2018 Full Interview
In this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston about the disease process of obesity.
Read More »George Bray Part 1, The Chronic Disease of Obesity
In part 1 of this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape about the primary messages from the World Obesity Federation position statements.
Read More »George Bray Part 2, The Problems and Limitations of Obesity
In part 2 of this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape about the inequality of obesity and the issues with moving forward in solving the obesity problem.
Read More »George Bray Part 3, Obesity Breakthroughs on the Horizon
In part 3, the conclusion of this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape about the possible methods and strategies for curtailing the obesity epidemic.
Read More »Diabetes and the Use of Complementary and Alternative Medicine
Herbal therapies and acupuncture among the most common alternative therapies used by patients with diabetes.
Read More »Patients With T2D, Mild Renal Impairment Can Benefit From A DPP-4 Inhibitor
Sitagliptin showed greater glycemic efficacy over dapagliflozin when added onto existing therapy.
Read More »Semaglutide Causes Weight Loss in Type 2 Diabetes Regardless of Baseline BMI
The SUSTAIN trials showed significant reductions in weight, but the true reason for the weight loss still unknown.
Read More »Overtreatment of Diabetes in Patients 75 Years or Older
Recent studies show one-quarter of the population over the age of 75 who have type 2 diabetes are tightly managed with medications and are high risk for hypoglycemia.
Read More »Dapagliflozin Improves Glycemic Index in Patients with T1DM but Increases Risk for DKA
SGLT shown as useful adjunctive agent when insulin monotherapy fails, but decrease in insulin use may prove harmful.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.